Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ERJP | ISIN: US00688A2050 | Ticker-Symbol:
NASDAQ
27.06.25 | 21:54
0,332 US-Dollar
-29,37 % -0,138
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADIAL PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ADIAL PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur ADIAL PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAdial signs manufacturing deals for alcohol disorder drug trials5
MiAdial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply296Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration...
► Artikel lesen
ADIAL PHARMACEUTICALS Aktie jetzt für 0€ handeln
18.06.Adial Pharmaceuticals Prices $3.6 Mln Public Offering With Accompanying Warrants2
17.06.Adial Pharmaceuticals announces pricing of $3.6M public offering1
16.06.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
13.06.ADIAL PHARMACEUTICALS, INC. - S-1/A, General form for registration of securities1
11.06.Adial Pharmaceuticals macht Fortschritte bei Phase-3-Studiendesign für Alkoholsuchtmittel5
11.06.EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial3
06.06.ADIAL PHARMACEUTICALS, INC. - S-1, General form for registration of securities3
30.05.Adial Pharmaceuticals files to register resale of 6.7M shares from warrant conversions2
30.05.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
15.05.Adial Pharmaceuticals reports Q1 results1
15.05.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update245GLEN ALLEN, Va., May 15, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies...
► Artikel lesen
15.05.ADIAL PHARMACEUTICALS, INC. - 8-K, Current Report1
14.05.ADIAL PHARMACEUTICALS, INC. - 10-Q, Quarterly Report2
13.05.Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study167Glen Allen, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies...
► Artikel lesen
08.05.FDA to Review Adial's Phase 3 Trial Plan for AUD Treatment2
08.05.EXCLUSIVE: Adial Pharmaceuticals Secures FDA End of Phase 2 Meeting Request To Discuss Upcoming Clinical Development Plan For Lead Program1
02.05.Adial Pharmaceuticals sichert sich 2,75 Millionen US-Dollar durch Optionsscheinausübung1
02.05.Adial Pharmaceuticals secures $2.75 million through warrant exercise1
Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1